Schade DS - Search Results

1

Hearing Impairment and Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.

Schade DS, Lorenzi GM, Braffett BH, Gao X, Bainbridge KE, Barnie A, Cruickshanks KJ, Dalton D, Diminick L, Gubitosi-Klug R, Kramer JR, Lachin JM, Larkin ME, Cowie CC; DCCT/EDIC Research Group. Schade DS, et al. Diabetes Care. 2018 Dec;41(12):2495-2501. doi: 10.2337/dc18-0625. Epub 2018 Sep 25. Diabetes Care. 2018. PMID: 30254082 Free PMC article.

2

Surgery and diabetes.

Schade DS. Schade DS. Med Clin North Am. 1988 Nov;72(6):1531-43. doi: 10.1016/s0025-7125(16)30720-9. Med Clin North Am. 1988. PMID: 3054366 Review.

3

Brittle diabetes: strategies, diagnosis, and treatment.

Schade DS. Schade DS. Diabetes Metab Rev. 1988 Jun;4(4):371-90. doi: 10.1002/dmr.5610040405. Diabetes Metab Rev. 1988. PMID: 3292175 Review. No abstract available.

4

Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.

Burge MR, Castillo KR, Schade DS. Burge MR, et al. Among authors: schade ds. Diabetes Care. 1997 Feb;20(2):152-5. doi: 10.2337/diacare.20.2.152. Diabetes Care. 1997. PMID: 9118763 Clinical Trial.

5

Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population.

Lindeman RD, Romero LJ, Hundley R, Allen AS, Liang HC, Baumgartner RN, Koehler KM, Schade DS, Garry PJ. Lindeman RD, et al. Among authors: schade ds. Diabetes Care. 1998 Jun;21(6):959-66. doi: 10.2337/diacare.21.6.959. Diabetes Care. 1998. PMID: 9614614

6

Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

Rassam AG, Zeise TM, Burge MR, Schade DS. Rassam AG, et al. Among authors: schade ds. Diabetes Care. 1999 Jan;22(1):133-6. doi: 10.2337/diacare.22.1.133. Diabetes Care. 1999. PMID: 10333914 Clinical Trial.

7

Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.

Burge MR, Zeise TM, Sobhy TA, Rassam AG, Schade DS. Burge MR, et al. Among authors: schade ds. Diabetes Care. 1999 Dec;22(12):2037-43. doi: 10.2337/diacare.22.12.2037. Diabetes Care. 1999. PMID: 10587839 Clinical Trial.

8

What are the barriers to medical care for patients with newly diagnosed diabetes mellitus?

Burge MR, Lucero S, Rassam AG, Schade DS. Burge MR, et al. Among authors: schade ds. Diabetes Obes Metab. 2000 Dec;2(6):351-4. doi: 10.1046/j.1463-1326.2000.00105.x. Diabetes Obes Metab. 2000. PMID: 11225964

9

Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.

Burge MR, Sood V, Sobhy TA, Rassam AG, Schade DS. Burge MR, et al. Among authors: schade ds. Diabetes Obes Metab. 1999 Jul;1(4):199-206. doi: 10.1046/j.1463-1326.1999.00031.x. Diabetes Obes Metab. 1999. PMID: 11228754 Review. No abstract available.

10

Repaglinide dose response? A clinician's viewpoint.

Schade DS. Schade DS. Diabetes Technol Ther. 1999 Fall;1(3):257-8. doi: 10.1089/152091599317152. Diabetes Technol Ther. 1999. PMID: 11475270 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters